From September 26, 2022 to October 11, 2022, the company has repurchased 1,046,200 shares, representing 0.24% for CNY 30.1 million. With this, the company has completed the repurchase of 1,046,200 shares, representing 0.24% for CNY 30.1 million under the buyback announced on September 26, 2022.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.34 CNY | -0.36% |
|
-0.58% | -9.38% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.38% | 1.76B | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-9.24% | 2.27B | |
+21.21% | 2.1B | |
-7.16% | 1.43B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on September 26, 2022.